{"id":329743,"date":"2026-10-28T10:49:51","date_gmt":"2026-10-28T05:19:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=329743"},"modified":"2026-10-28T10:49:51","modified_gmt":"2026-10-28T05:19:51","slug":"why-concord-biotech-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-concord-biotech-share-price-fall-today-2026\/","title":{"rendered":"Concord Biotech (CONCORDBIO) Share Price Falls 7.65% to Rs 1,272.9 on 28 October 2026"},"content":{"rendered":"
Concord Biotech (CONCORDBIO)<\/a> share price fell to Rs 1,272.9 today, down 7.65% from the previous close. Market cap was Rs 13,666.01 crore.<\/em><\/div>\n

The Concord Biotech Share Price stood at Rs 1,272.9 on 28 October 2026, down 7.65% from the previous close of Rs 1,378.35, a fall of Rs 105.45 per share. The Mid Cap company, listed under the symbol CONCORDBIO, carries a market capitalisation of Rs 13,666.01 crore.<\/p>\n

This share price fall matters because the move is large for a single session and the stock sits in the Pharmaceuticals & Drugs industry, where the benchmark covers 199 companies. Concord Biotech reports a P\/E ratio of 52.36 and a P\/B ratio of 6.95, against industry medians of 30.74 and 2.71. The sections below set out what happened, the fundamentals, the sector benchmark and the peer picture, so readers can follow the Concord Biotech Stock News in one place.<\/p>\n

What should investors monitor next? The Concord Biotech Share Price Today relative to the previous close, the valuation gap against the industry benchmark, and any company announcement that explains the decline. Univest tracks all three on its stock page.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n